Hong Kong's Grade A office market gained momentum in Q4 (up to mid-November), with overall net absorption rising to 476,000 ...

There is a significant unmet need for additional treatment options for high-grade NMIBC, especially in those ineligible for BCG.

Cedarville University: A group of third graders dashed across a field, ropes in hand, learning about transportation the ...

Sacituzumab tirumotecan demonstrated a 31% objective response rate and 71% disease control rate in advanced urothelial ...

IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...

Follow a clear workflow, wireframes to hero, testimonials, features, pricing, and FAQ, to ship client-ready designs quickly ...

Vistra's long-term rating upgraded at S&P to investment grade BBB-, saying its exposure to fluctuating wholesale power prices ...

And vacancy tightened to 0.7%. Elevated global uncertainty continues to weigh on sentiment, but Japan’s outlook is steadily ...

KeyCorp is set for growth with bullish momentum, strong earnings, and a 4.26% yield. Click here to read my most recent ...

In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically ...

“Olomorasib, in combination with pembrolizumab, has demonstrated significant efficacy and a manageable safety profile in patients with KRAS G12C-mutant advanced/metastatic NSCLC, including patients ...

Kingstown, St. Vincent and the Grenadines, December 10th, 2025, Chainwire Bitunix exchange has announced new partnerships ...